Back to CVE records
Critical 9.3Published Oct 20, 2026

CVE-2026-93475Out-of-bounds Write via an Unbounded RSA Modulus in NetX Secure X.509

Updated under an hour ago ()

Does this affect you?

It affects Eclipse Foundation Eclipse ThreadX - NetX Duo. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

The X.509 parser in NetX Secure accepts an RSA public key of any size, but every signature-verification path decrypts into fixed-size buffers dimensioned for the `NX_CRYPTO_MAX_RSA_MODULUS_SIZE` default of 4096 bits. A certificate carrying a larger modulus drives an out-of-bounds write past a file-scope static during ordinary certificate-chain verification. It is reachable pre-authentication. The issuer used for the crypto operation is looked up in the remote, peer-supplied store before the trusted store, so the attacker supplies the oversized key themselves as an intermediate in the chain they present. It triggers on a TLS or DTLS client verifying a malicious server's chain, and on a server performing client-certificate authentication.

CVSS
9.3 CRITICAL (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N
Weakness (CWE)
CWE-787, CWE-1284
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
eclipse
NVD analysis
Awaiting Analysis
Record last updated
Oct 20, 2026
First seen by InfoSec Signals
Oct 20, 2026

Affected products

Affected products
Eclipse Foundation Eclipse ThreadX - NetX Duo
eclipse_foundation:eclipse_threadx_netx_duo (from the name)
through 6.5.1.202602; 6.5.2.202603 not affected
CNA record

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.